Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.
The Covaris technological foundation is based on its proprietary and patented AFA™ technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in Genomics, Proteomics, Cell Biology and Drug Discovery, and Formulation. Thousands of Focused-ultrasonicators are in use in over 30 countries and customers include the world’s leading researchers, universities, and pharmaceutical companies.
Covaris also develops devices and workflow systems to improve the discovery and measurement of molecules and biomarkers in tissue. CryoPrep™, tissueTUBE™ and t-PREP™ enable a tissue samples to be thermally stabilized, reconfigured and chemically stabilized in a system that produces high extraction yields.
Covaris continues to innovate pre-analytical sample preparation technologies to help accelerate the pace of research and drug discovery.